Effects of cyclosporin A on the development of osteonecrosis in rabbits

Acta Orthopaedica

Volumn 77, Issue 5, 2006, Pages 813-819

  Miyanishi, Keita ^a   Yamamoto, Takuaki ^a   Irisa, Takahiko ^a   Yamashita, Akihisa ^a   Motomura, Goro ^a   Jingushi, Seiya ^a   Iwamoto, Yukihide ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; METHYLPREDNISOLONE ACETATE; PENTOBARBITAL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE NECROSIS; CONTROLLED STUDY; DRUG EFFECT; FEMUR HEAD; HISTOPATHOLOGY; HUMERUS; MALE; NONHUMAN; RABBIT; SINGLE DRUG DOSE; STEROID THERAPY;

ANIMALS; CYCLOSPORINE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMUR HEAD NECROSIS; GLUCOCORTICOIDS; IMMUNOSUPPRESSIVE AGENTS; METHYLPREDNISOLONE; ORGAN TRANSPLANTATION; RABBITS;

EID: 33749490071     PISSN: 17453674     EISSN: 17453682     Source Type: Journal    
DOI: 10.1080/17453670610013042     Document Type: Article

References (22)

1. Allison G T, Bostrom M P, Glesby M J. Osteonecrosis in HIV disease: epidemiology, etiologies, and clinical management. Aids 2003; 17: 1-9.
2. Andersen H, Madsen G, Nordestgaard B G, Hansen BF, Kjeldsen K, Stender S. Cyclosporin suppresses transplant arteriosclerosis in the aorta-allografted, cholesterolclamped rabbit. Suppression preceded by decrease in arterial lipoprotein permeability. Arterioscler Thromb 1994; 14: 944-50.
3. Colak T, Karakayali H, Yagmurdur M C, Moray G. Effect of conversion from cyclosporine to tacrolimus on lipid profiles in renal transplant recipients. Transplant Proc 2002; 34: 2081-2.
4. Dunn D C, White D J, Herbertson B M, Wade J. Prolongation of kidney survival during and after cyclosporin A therapy. Transplantation 1979; 27: 359-61.
5. Durak I, Karabacak H I, Buyukkocak S, Cimen M Y, Kacmaz M, Omeroglu E, Ozturk H S. Impaired antioxidant defense system in the kidney tissues from rabbits treated with cyclosporine. Protective effects of vitamins E and C. Nephron 1998; 78: 207-11.
6. Fink J C, Leisenring W M, Sullivan K M, Sherrard D J, Weiss N S. Avascular necrosis following bone marrow transplantation: a case-control study. Bone 1998; 22: 67-71.
7. Glueck C J, Freiberg R, Glueck H I, Henderson C, Welch M, Tracy T, Stroop D, Hamer T, Sosa F, Levy M. Hypofibrinolysis: a common, major cause of osteonecrosis. Am J Hematol 1994; 45: 156-66.
8. Green C J, Allison A C. Extensive prolongation of rabbit kidney allograft survival after short-term cyclosporin-A treatment. Lancet 1978; 1 (8075): 1182-3.
9. Guillemain R, Farge D, Amrein C, Vulser C, Bruneval P, Jacquot C, Carpentier A. Thrombotic microangiopathy with reversible acute renal failure in a cardiac transplant recipient under cyclosporin. Clin Nephrol 1990; 34: 237-8.
10. Jones J P, Jr. Fat embolism, intravascular coagulation and osteonecrosis. Clin Orthop 1993; (292): 294-308.
11. Kawai T, Sakurabayashi I, Koide A. Fractional quantitation of serum beta-lipoprotein by a simple turbidimetric method. Protides of the biological fluids. Oxford and New York, Pergamon Press, 1978: 415.
12. Kubo T, Yamazoe S, Sugano N, Fujioka M, Naruse S, Yoshimura N, Oka T, Hirasawa Y. Initial MRI findings of non-traumatic osteonecrosis of the femoral head in renal allograft recipients. Magn Reson Imaging 1997; 15: 1017-23.
13. Kubo T, Fujioka M, Yamazoe S, Yoshimura N, Oka T, Ushijima Y, Hasegawa Y, Hirasawa Y. Relationship between steroid dosage and osteonecrosis of the femoral head after renal transplantation as measured by magnetic resonance imaging. Transplant Proc 1998; 30: 3039-40.
14. Landmann J, Renner N, Gachter A, Thiel G, Harder F. Cyclosporin A and osteonecrosis of the femoral head. J Bone Joint Surg (Am) 1987; 69: 1226-8.
15. Langhoff E, Madsen S, Flachs H, Olgaard K, Ladefoged J, Hvidberg E F. Inhibition of prednisolone metabolism by cyclosporine in kidney-transplanted patients. Transplantation 1985; 39: 107-9.
16. Lieberman J R, Scaduto A A, Wellmeyer E. Symptomatic osteonecrosis of the hip after orthotopic liver transplantation. J Arthroplasty 2000; 15: 767-71.
17. Miyanishi K, Yamamoto T, Irisa T, Yamashita A, Jingushi S, Noguchi Y, Iwamoto Y. Bone marrow fat cell enlargement and a rise in intraosseous pressure in steroid-treated rabbits with osteonecrosis. Bone 2002; 30: 185-90.
18. Nakata K, Masuhara K, Nakamura N, Shibuya T, Sugano N, Matsui M, Ochi T, Ohzono K. Inducible osteonecrosis in a rabbit serum sickness model: deposition of immune complexes in bone marrow. Bone 1996; 18: 609-15.
19. Powles R L, Clink H M, Spence D, Morgenstern G, Watson J G, Selby P J, Woods M, Barrett A, Jameson B, Sloane J, Lawler S D, Kay H E, Lawson D, McElwain T J, Alexander P. Cyclosporin A to prevent graft-versus-host disease in man after allogeneic bone-marrow transplantation. Lancet 1980; 1 (8164): 327-9.
20. Torii Y, Hasegawa Y, Kubo T, Kodera Y, Minami S, Morishita Y, Yamada Y, Iwata H. Osteonecrosis of the femoral head after allogeneic bone marrow transplantation. Clin Orthop 2001; (382): 124-32.
21. Vanrenterghem Y, Roels L, Lerut T, Gruwez J, Michielsen P, Gresele P, Deckmyn H, Colucci M, Arnout J, Vermylen J. Thromboembolic complications and haemostatic ch anges in cyclosporin-treated cadaveric kidney allograft recipients. Lancet 1985; 1 (8436): 999-1002.
22. Yamamoto T, Irisa T, Sugioka Y, Sueishi K. Effects of pulse methylprednisolone on bone and marrow tissues. Arthritis Rheum 1997; 40: 2055-64.